| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-16 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.42 | 3e-15 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-14 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.47 | 2e-14 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.44 | 2e-10 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.42 | 2e-09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-09 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.31 | 4e-07 |